Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45000 participants
OBSERVATIONAL
2014-08-31
2030-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
NCT04464655
Cardiac MR of Subclinical CVD: Impact of Age
NCT00041418
Myocardial and Arterial Phenotype of Coronary Artery Disease
NCT06202300
Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure
NCT01281384
Cardiac FDG PET Viability Registry
NCT00766987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are engaged by automated, tablet-based tools to collect informed consent and deploy standardized patient health assessments. Standardized reporting of disease features are captured using bespoke reporting tools. All patients are prospectively followed for a period of 10-years using linkage to administrative health data, inclusive of ICD-coded events, laboratory test results, ECG and vital statistics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with known or suspected cardiovascular disease
All patients with known or suspected cardiovascular disease are studied with a-priori stratification of specific disease-based cohorts.
Diagnostic testing performed as per routine care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic testing performed as per routine care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alberta Health services
OTHER
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James White
MD, FRCP(C) Director - Stephenson Cardiac Imaging Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James White
Role: PRINCIPAL_INVESTIGATOR
Director of Stephenson Cardiac Imaging Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foothills Medical Centre
Calgary, Alberta, Canada
South Health Campus
Calgary, Alberta, Canada
Peter Lougheed Hospital
Calgary, Alberta, Canada
Rockyview Hospital
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
James A White, MD
Role: primary
James A White, MD
Role: primary
James A White, MD
Role: primary
James A White, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Purmah Y, Lei LY, Dykstra S, Mikami Y, Cornhill A, Satriano A, Flewitt J, Rivest S, Sandonato R, Seib M, Lydell CP, Howarth AG, Heydari B, Merchant N, Bristow M, Fine N, Gaztanaga J, White JA. Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events: A Cardiac MRI Based Study of 7131 Patients With Known or Suspected Cardiovascular Disease. Circ Cardiovasc Imaging. 2021 Mar;14(3):e011337. doi: 10.1161/CIRCIMAGING.120.011337. Epub 2021 Mar 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB13-0902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.